"We chose Paracelsus to help us with our first IND application because of Dr. Grace Furman’s prominent reputation in the toxicology arena and her extensive experience..."
Ken Stauderman, VP Research

Professional Toxicology Services

Paracelsus, Inc.

As CEO/President of Paracelsus, Inc., Dr. Furman provides professional toxicology services to the pharmaceutical industry as an independent consultant.  Dr. Furman made the decision to become independent in mid 2006, at which time she was Senior Director of Regulatory Safety Assessment in Pfizer’s Drug Safety Research and Development department.  

Dr. Furman began her professional career in Cincinnati as a divisional toxicologist in Procter & Gamble’s Health Care Sector (1992-1994).  In 1994, Dr. Furman migrated to San Diego to accept a position as sole toxicologist with DepoTech Corporation (now Pacira Pharmaceuticals, Inc.), where she was instrumental in building the preclinical development group (1994-1999).  Dr. Furman’s first opportunity to explore independent consulting came unexpectedly in early 1999 as a result of corporate restructuring and a concurrent lack of professional prospects within the San Diego area.  Later that same year, an attractive position within Agouron Pharmaceuticals, Inc. lured Dr. Furman back into industry.  Through a subsequent series of mergers and acquisition, the Agouron opportunity developed into the position Dr. Furman held within Pfizer’s Global R&D division through 2006.  In late 2006, Dr. Furman founded Paracelsus, Inc. and became its first (and only) employee.  Paracelsus commenced conducting business as a corporate entity in January 2007.  Dr. Furman’s area of professional expertise relates to regulatory toxicology as applied to development of novel small molecule therapeutics.   

Dr. Furman received her Ph.D. in Biomedical Sciences with a specialization in toxicology from Northeastern University in Boston, MA (1992).  She also holds a B.S. in toxicology (1986) and is a Diplomate of the American Board of Toxicology (2000).  Dr. Furman is an active member of the Society of Toxicology (SOT) and the American College of Toxicology (ACT) and has served on ACT’s Nominating Committee (2008) and on Council (2009-2011).  Dr. Furman is also an active member of the Southern California Chapter of the Society of Toxicology and has held several Executive Council positions, include President, within this Regional Chapter.  Dr. Furman is chair emeritus of the San Diego Biotechnology Discussion Group and a founding member of San Diego’s Women in Biosciences.  Additionally, Dr. Furman is an instructor for UCSD Extension, where her “Toxicology in Drug Discovery and Development” classroom and distance-learning courses are offered through the Drug Discovery and Development and AMDET Process Certificate Programs.    

Click here for a copy of Dr. Furman's curriculum vitae